Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alnumed is a specialized biotechnology company based in Regensburg, Germany, that focuses on Nuclear Magnetic Resonance (NMR) spectroscopy for the analysis of complex biological and chemical mixtures. The company provides high-throughput metabolomics services and quality control solutions for the pharmaceutical, food, and beverage industries. By leveraging advanced NMR technology, Alnumed enables the identification and quantification of metabolites to support clinical research, drug development, and product authenticity testing. Their expertise spans from sample preparation to sophisticated bioinformatic data analysis, offering a robust platform for biomarker discovery and metabolic profiling. The company operates out of the BioPark Regensburg, serving a global client base in both the life sciences and food sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alnumed.